Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-04-05 4:05 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | Point72 Asset Management L.P. | 5,932,908 7.9% | 5,932,908 (New Position) | View |
2024-02-13 12:16 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 5,778,188 9.5% | 213,089 (+3.83%) | View |
2024-02-12 06:06 am Purchase | 13G | SUTRO BIOPHARMA INC. STRO | Rubric Capital Management LP | 3,344,810 5.49% | 132,938 (+4.14%) | View |
2024-02-07 07:56 am Purchase | 13G | SUTRO BIOPHARMA INC. STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,467,796 7.33% | 918,476 (+25.88%) | View |
2024-01-24 5:23 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | BlackRock Inc. BLK | 5,823,922 9.6% | 963,782 (+19.83%) | View |
2024-01-17 4:54 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | INTEGRATED CORE STRATEGIES (US) LLC | 3,451,825 5.7% | 3,451,825 (New Position) | View |
2023-10-10 4:52 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,549,320 5.86% | 3,549,320 (New Position) | View |
2023-02-14 3:00 pm Sale | 13G | SUTRO BIOPHARMA INC. STRO | EVENTIDE ASSET MANAGEMENT LLC | 0 0% | -2,708,975 (Position Closed) | View |
2023-02-14 11:45 am Purchase | 13G | SUTRO BIOPHARMA INC. STRO | BIOTECHNOLOGY VALUE FUND L P | 3,347,946 5.8% | 187,530 (+5.93%) | View |
2023-02-13 10:56 am Purchase | 13G | SUTRO BIOPHARMA INC. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 5,565,099 9.7% | 3,091,304 (+124.96%) | View |
2023-02-10 4:00 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | Rubric Capital Management LP | 3,211,872 5.59% | 3,211,872 (New Position) | View |
2023-02-07 2:55 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | BlackRock Inc. BLK | 4,860,140 8.5% | 1,160,097 (+31.35%) | View |
2023-02-01 1:09 pm Sale | 13G | SUTRO BIOPHARMA INC. STRO | FRANKLIN RESOURCES INC BEN | 2,838,135 4.9% | -429,812 (-13.15%) | View |
2023-01-23 4:31 pm Sale | 13G | SUTRO BIOPHARMA INC. STRO | MILLENNIUM MANAGEMENT LLC | 1,369,021 2.4% | -1,053,652 (-43.49%) | View |
2022-07-08 4:19 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | MILLENNIUM MANAGEMENT LLC | 2,422,673 5.2% | 2,422,673 (New Position) | View |
2022-02-14 12:00 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | EVENTIDE ASSET MANAGEMENT LLC | 2,708,975 5.9% | 338,000 (+14.26%) | View |
2022-02-11 4:49 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 2,473,795 5.4% | 65,400 (+2.72%) | View |
2022-02-04 1:45 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | FRANKLIN RESOURCES INC BEN | 3,267,947 7.1% | 3,267,947 (New Position) | View |
2022-02-02 7:18 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | BlackRock Inc. BLK | 3,700,043 8% | 982,114 (+36.13%) | View |
2022-01-18 5:18 pm Purchase | 13G | SUTRO BIOPHARMA INC. STRO | BIOTECHNOLOGY VALUE FUND L P | 3,160,416 6.8% | 1,306,254 (+70.45%) | View |